Please assess the completion status of the following clinical trial:

Trial Title: Simplifying the Rabies Pre-exposure Vaccination

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Willingness to provide written consent~* Seronegative for rabies~* Belgian soldiers who are deployable and visit the Travel clinic in Brussels during their preparation phase before deployment OR military students at the schools of Belgian Defense are eligible in preparation of an overseas exercise or during the scheduled vaccination program at the end of their studies~* Prepared to follow the study schedule~Exclusion Criteria:~* Subjects who have had rabies vaccination (complete or incomplete) in the past due to post-exposure prophylaxis.~* Subjects with a known allergy to one of the components of the vaccine.~* Immune depressed persons or intake of immunodepressant medication.~* Subjects who take mefloquine~* Planned deployment to overseas areas within 35 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 47 Years
- Healthy Volunteers: t

Study Arms:
- Standard vaccination schedule (Type: ACTIVE_COMPARATOR): One injection will be given on three different days (day 0, day 7 and day 21 or 28)
- Accelerated vaccination schedule (Type: EXPERIMENTAL): Two injections will be given on the same day (day 0 and day 7): one on each forearm.

Based on this trial design, predict the completion outcome and termination type (if applicable).